The investment objective is to provide above-average capital growth over the medium to long term principally by tracking the performance of the FTSE4Good UK Index. The Scheme may also invest in other investments to the extent permitted by the COLL Sourcebook as applicable from time to time and explained in this Prospectus.
Name | % Net Assets |
---|---|
BP | 9.2% |
Royal Dutch Petroleum | 8.1% |
HSBC Holdings | 7.8% |
GlaxoSmithKline | 6.0% |
Vodafone Group | 4.7% |
Royal Bank of Scotland | 4.3% |
Barclays | 3.1% |
AstraZeneca | 3.0% |
HBOS | 3.0% |
Lloyds TSB Group | 2.2% |
Key | % Net Assets |
---|---|
BP | 9.2% |
Royal Dutch Petroleum | 8.1% |
HSBC Holdings | 7.8% |
GlaxoSmithKline | 6.0% |
Other | 68.9% |
Date | 21-Nov-2024 |
---|---|
NAV | 307.40p |
Currency | GBP |
Change | 1.40p |
% | 0.46% |
YTD change | 24.60p |
YTD % | 8.70% |
Fund Inception | 29/09/2003 |
---|---|
Fund Manager | Neil Blower |
TER | 1.50 (31-Dec-2008) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £500 |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.00% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.32 |
You are here: research